L'Oréal vs Sanofi

Hightouch Names Matthew Lubeck General Manager EMEA

Hightouch, a leader in data and AI for marketing, has appointed Matthew Lubeck as General Manager for EMEA. Based in London, Lubeck will lead all go-to-market functions across the region as Hightouch drives adoption of agentic marketing. The company reports over 100% growth in each of the past two years and recently closed a $150 million Series D. Hightouch already has offices in London and Paris, native-speaking teams across multiple European markets, and a new team in Dubai. Lubeck brings 20 years of experience, having previously launched and led Amperity's EMEA business and held leadership roles at L'Oréal and Estée Lauder. Hightouch's platform supports EU data residency and runs inside customers' data warehouses, with clients including Accor, HelloFresh, Currys, and Telenor.

• Hightouch appoints Matthew Lubeck as General Manager EMEA, based in London.
• Lubeck previously launched and led EMEA business at Amperity.
• Hightouch reported over 100% growth in each of the past two years.

L'Oréal rolls out internal GPT to 90,000 employees

In a podcast interview, L'Oréal's DACH CIO Arooj Humayun detailed the company's three-stage plan for integrating generative AI across its 90,000 employees. The plan includes awareness building, training, and tool deployment. To ensure data privacy and compliance with stringent German regulations, L'Oréal developed its own internal platform, L'Oréal GPT, which runs on-premise and uses vetted large language models. This prevents any data from leaving the company. Additionally, they use a tool called CreateTech for image generation. The company is now moving towards AI agents, dubbed 'Companions', which can execute actions like booking travel. Usage is measured via anonymized prompt counts. The initiative aims to empower employees in various departments, including finance, HR, and marketing, to automate repetitive tasks.

• L'Oréal has 90,000 employees.
• L'Oréal developed its own internal AI platform called L'Oréal GPT.
• L'Oréal GPT runs on-premise and uses vetted large language models.

Omnicom Media Group Wins L'Oréal's €350M Media Account

The Omnicom Media Group has won the media pitch for L'Oréal's €350 million account. The dedicated agency for the cosmetics giant will be named Beauty Co-Lab. The new agency is set to launch in January 2027. This follows the recent announcement that Wavemaker, the incumbent, lost the account. The article provides details on the agency structure and confirms the name of the new entity, but the full details are behind a paywall.

Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

6-K Financial Filing Analysis for Sanofi (2026-08-06)

Sanofi filed a Form 6-K on August 6, 2026, incorporating a press release announcing European Union approval for MenQuadfi. The vaccine has received expanded marketing authorization in the EU for immunization against invasive meningococcal disease in infants starting from six weeks of age. This regulatory milestone expands the target patient demographic for MenQuadfi, bolstering Sanofi Vaccines' pediatric portfolio and competitive standing across European healthcare markets.

• MenQuadfi received EU regulatory approval for protection against invasive meningococcal disease in infants from age six weeks.
• The official press release detailing the approval was issued on August 4, 2026, and submitted via Form 6-K on August 6, 2026.

6-K Financial Filing Analysis for Sanofi (2026-09-17)

On September 17, 2026, Sanofi submitted a Form 6-K filing with the U.S. Securities and Exchange Commission incorporating a press release dated September 14, 2026. The filing announces a new strategic partnership between Sanofi and Cheplapharm focused on mature medicines. This partnership reflects Sanofi's ongoing portfolio optimization strategy, allowing the company to streamline operations, monetize or efficiently manage established pharmaceutical assets, and reallocate focus and capital toward core growth drivers and innovative pipeline therapies.

• Sanofi entered into a strategic partnership with Cheplapharm focused on its mature medicines portfolio, originally announced via press release on September 14, 2026.
• The Form 6-K regulatory submission was formally executed and signed on September 17, 2026, by Alexandra Roger, Head of Legal Corporate & Finance.